Nilai Dipunlarasaken Utang lan Kas: TuHURA Biosciences, Inc. (HURA)

Tandha merek TuHURA Biosciences (HURA)

The price chart for TuHURA Biosciences, Inc. (HURA) reflects a business valuation that currently stands at 134.57. The company's revenue will be based on the commercialization of personalized vaccines and immune stimulants. The current state is characterized by the depletion of reserves due to testing costs amid zero sales. Meanwhile, skilled management is focusing on developing cutting-edge therapeutic systems while raising funds to complete trials.

HURA TuHURA Biosciences, Inc.: Nilai Perusahaan ing interval 23.11.2025 - 30.10.2026

Ringkesan rincian data analitis TuHURA Biosciences (HURA)

- rega pasar lan target rega analis:
Rega saham TuHURA Biosciences Inc.|HURA - Bagan rega target
- indikator kapitalisasi bursa perusahaan:
Nilai pasar TuHURA Biosciences|HURA - Nilai Perusahaan
- informasi kapitalisasi buku:
Nilai Buku saben Saham TuHURA Biosciences|HURA - Kapitalisasi Buku|Rasio Kapitalisasi marang Aset Bersih tuhurabio.com|HURA - Total Aset Perusahaan
- rincian struktur utang lan likuiditas bisnis:
Total Utang marang Modal TuHURA Biosciences, Inc.|HURA - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang modal TuHURA Biosciences Inc.|HURA - Gunggung utang perusahaan|Utang marang nilai buku TuHURA Biosciences|HURA - Utang jangka dawa perusahaan|Utang jangka cendhak TuHURA Biosciences|Rasio jangkoan perantara tuhurabio.com
- data bathi bisnis lan rasio investasi:
HURA - Penghasilan resik
Ringkesan analitik perusahaan:HURA - TuHURA Biosciences, Inc.
Produk asli TuHURA Biosciences, Inc.

Defensive assets are selected based on the criterion of undervalued acquisition costs, which is critical for TuHURA Biosciences (HURA) and its developments in the field of anti-cancer vaccines. The current value of 134.57 reflects the real business price, summing market capitalization and debt minus cash, allowing the use of a historical enterprise value chart to identify entry points without the risk of overpaying for the asset.

Karo sapa TuHURA Biosciences, Inc. saingan

Nilai Perusahaan BeiGene Ltd. ONC|HALO - Nilai Total Perusahaan|Nilai Dipunlarasaken Utang lan Kas RVMD (Revolution Medicines Corp)|AAPG: Nilai Perusahaan|cgoncology.com (CGON) - Nilai Perusahaan|URGN (UroGen Pharma) - Nilai Perusahaan|Rega Nyata Tumbas Perusahaan Kanthi Wutuh Bicara Therapeutics Inc (BCAX)|Nilai Perusahaan PSNL|Nilai Perusahaan Erasca Oncology (ERAS)|Nilai Total Perusahaan Delcath Systems, Inc. DCTH|YMAB: Nilai Bisnis|Aura Biosciences - Nilai Perusahaan|Candel Therapeutics (CADL) - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|ARAY: Nilai Perusahaan|Total Nilai Perusahaan SELLAS Life Sciences Group (SLS)|Nilai Total Perusahaan Actuate Therapeutics, Inc.|CTOR: Nilai Dipunlarasaken Utang lan Kas|Rega Nyata Tumbas Perusahaan Kanthi Wutuh TARA (Protara Therapeutics, Inc.)|FATE (Fate Therapeutics Inc) - Nilai Dipunlarasaken Utang lan Kas|Nilai Perusahaan WHWK (Aadi Bioscience)|TCRX - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|CSBR: Rega Nyata Tumbas Perusahaan Kanthi Wutuh|XBIT - Nilai Perusahaan|cel-sci.com (CVM) - Nilai Total Perusahaan|OS Therapies Inc. - Nilai Dipunlarasaken Utang lan Kas|RADX (Radiopharm Theranostics) - Nilai Perusahaan|Total Nilai Perusahaan Artiva ARTV|Rega Nyata Tumbas Perusahaan Kanthi Wutuh ANL (Adlai Nortye Ltd.)|Total Nilai Bisnis VERU|Tempest Therapeutics, Inc. - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|Nilai Perusahaan Xilio Therapeutics Inc XLO|Enochian BioSciences - Nilai Perusahaan|Nilai Dipunlarasaken Utang lan Kas MURA (Mural Oncology plc)|KAPA (kairospharma.com) - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|OnKure Therapeutics (OKUR) - Nilai Perusahaan|Nilai Total Perusahaan CytoMed Therapeutics Ltd|CRIS: Nilai Dipunlarasaken Utang lan Kas|Nilai Perusahaan APLM|Nilai Perusahaan Tharimmune Corporation (THAR)|Advanced Biomed - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|Nilai Dipunlarasaken Utang lan Kas GNPX|Calidi Bio - Nilai Perusahaan|SBFM: Nilai Total Perusahaan|XBIO: Nilai Perusahaan|SLRX - Rega Tumbas Perusahaan|Nilai Total Perusahaan Purple Biotech|Total Nilai Perusahaan AON AONC|Nilai Total Perusahaan BeiGene (BGNE)|Rega Tumbas Perusahaan Checkpoint Therapeutics Inc.|Nilai Perusahaan ELEV (Elevation Oncology)|ICAD - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|Ikena - Nilai Perusahaan|Rega Tumbas Perusahaan notablelabs.com NTBL|VIRX: Nilai Perusahaan|Total Nilai Perusahaan MorphoSys Inc (MOR)|Nilai Total Perusahaan NAYA Bio|Nilai Bisnis AAPGV (Ascentage)